BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Caro C, Iannone LF, Citraro R, Striano P, De Sarro G, Constanti A, Cryan JF, Russo E. Can we 'seize' the gut microbiota to treat epilepsy? Neurosci Biobehav Rev 2019;107:750-64. [PMID: 31626816 DOI: 10.1016/j.neubiorev.2019.10.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Mejía-granados DM, Villasana-salazar B, Lozano-garcía L, Cavalheiro EA, Striano P. Gut-microbiota-directed strategies to treat epilepsy: clinical and experimental evidence. Seizure 2021;90:80-92. [DOI: 10.1016/j.seizure.2021.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Miljanovic N, Potschka H. The impact of Scn1a deficiency and ketogenic diet on the intestinal microbiome: A study in a genetic Dravet mouse model. Epilepsy Res 2021;178:106826. [PMID: 34839144 DOI: 10.1016/j.eplepsyres.2021.106826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chatzikonstantinou S, Gioula G, Kimiskidis VK, McKenna J, Mavroudis I, Kazis D. The gut microbiome in drug-resistant epilepsy. Epilepsia Open 2021;6:28-37. [PMID: 33681645 DOI: 10.1002/epi4.12461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Iannone LF, Gómez-Eguílaz M, Citaro R, Russo E. The potential role of interventions impacting on gut-microbiota in epilepsy. Expert Rev Clin Pharmacol 2020;13:423-35. [PMID: 32320306 DOI: 10.1080/17512433.2020.1759414] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
5 Russo E. The gut microbiota as a biomarker in epilepsy. Neurobiol Dis 2021;163:105598. [PMID: 34942335 DOI: 10.1016/j.nbd.2021.105598] [Reference Citation Analysis]
6 Aygun H, Akin AT, Kızılaslan N, Sumbul O, Karabulut D. Probiotic supplementation alleviates absence seizures and anxiety- and depression-like behavior in WAG/Rij rat by increasing neurotrophic factors and decreasing proinflammatory cytokines. Epilepsy & Behavior 2022;128:108588. [DOI: 10.1016/j.yebeh.2022.108588] [Reference Citation Analysis]
7 Ceccarani C, Viganò I, Ottaviano E, Redaelli MG, Severgnini M, Vignoli A, Borghi E. Is Gut Microbiota a Key Player in Epilepsy Onset? A Longitudinal Study in Drug-Naive Children. Front Cell Infect Microbiol 2021;11:749509. [PMID: 34926315 DOI: 10.3389/fcimb.2021.749509] [Reference Citation Analysis]
8 Riva A, Pozzati E, Grasso M, De Caro C, Russo E, Verrotti A, Striano P. Targeting the MGBA in epilepsy: New insights from preclinical and clinical studies. Neurobiol Dis 2022;:105758. [PMID: 35588991 DOI: 10.1016/j.nbd.2022.105758] [Reference Citation Analysis]
9 Saad AK, Akour A, Mahboob A, Aburuz S, Sadek B. Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities. Pharmaceuticals 2022;15:612. [DOI: 10.3390/ph15050612] [Reference Citation Analysis]
10 Şafak B, Altunan B, Topçu B, Eren Topkaya A. The gut microbiome in epilepsy. Microbial Pathogenesis 2020;139:103853. [DOI: 10.1016/j.micpath.2019.103853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
11 Hopson LM, Singleton SS, David JA, Basuchoudhary A, Prast-Nielsen S, Klein P, Sen S, Mazumder R. Bioinformatics and machine learning in gastrointestinal microbiome research and clinical application. Prog Mol Biol Transl Sci 2020;176:141-78. [PMID: 33814114 DOI: 10.1016/bs.pmbts.2020.08.011] [Reference Citation Analysis]
12 Ding X, Zhou J, Zhao L, Chen M, Wang S, Zhang M, Zhang X, Jiang G. Intestinal Flora Composition Determines Microglia Activation and Improves Epileptic Episode Progress. Front Cell Infect Microbiol 2022;12:835217. [DOI: 10.3389/fcimb.2022.835217] [Reference Citation Analysis]
13 Bonnechère B, Amin N, van Duijn C. The Role of Gut Microbiota in Neuropsychiatric Diseases – Creation of An Atlas-Based on Quantified Evidence. Front Cell Infect Microbiol 2022;12:831666. [DOI: 10.3389/fcimb.2022.831666] [Reference Citation Analysis]
14 Mitrea L, Nemeş SA, Szabo K, Teleky BE, Vodnar DC. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Front Med (Lausanne) 2022;9:813204. [PMID: 35433746 DOI: 10.3389/fmed.2022.813204] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Kilinc E, Ankarali S, Ayhan D, Ankarali H, Torun IE, Cetinkaya A. Protective effects of long-term probiotic mixture supplementation against pentylenetetrazole-induced seizures, inflammation and oxidative stress in rats. J Nutr Biochem 2021;98:108830. [PMID: 34333116 DOI: 10.1016/j.jnutbio.2021.108830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ding M, Lang Y, Shu H, Shao J, Cui L. Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics. Front Immunol 2021;12:742449. [PMID: 34707612 DOI: 10.3389/fimmu.2021.742449] [Reference Citation Analysis]
17 Zubareva OE, Melik-kasumov TB. The Gut–Brain Axis and Peroxisome Proliferator-Activated Receptors in the Regulation of Epileptogenesis. J Evol Biochem Phys 2021;57:743-60. [DOI: 10.1134/s0022093021040013] [Reference Citation Analysis]
18 Raimondi I, Izzo L, Tunesi M, Comar M, Albani D, Giordano C. Organ-On-A-Chip in vitro Models of the Brain and the Blood-Brain Barrier and Their Value to Study the Microbiota-Gut-Brain Axis in Neurodegeneration. Front Bioeng Biotechnol 2019;7:435. [PMID: 31998702 DOI: 10.3389/fbioe.2019.00435] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
19 Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 2021;172:105840. [PMID: 34450312 DOI: 10.1016/j.phrs.2021.105840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Avorio F, Cerulli Irelli E, Morano A, Fanella M, Orlando B, Albini M, Basili LM, Ruffolo G, Fattouch J, Manfredi M, Russo E, Striano P, Carabotti M, Giallonardo AT, Severi C, Di Bonaventura C. Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence. Front Neurol 2021;12:705126. [PMID: 34421803 DOI: 10.3389/fneur.2021.705126] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zeng XD, Hu WG. Spontaneous remission of infantile spasms following rotavirus gastroenteritis. Neurol Sci 2021;42:253-7. [PMID: 32632632 DOI: 10.1007/s10072-020-04564-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Guo C, Huo YJ, Li Y, Han Y, Zhou D. Gut-brain axis: Focus on gut metabolites short-chain fatty acids. World J Clin Cases 2022; 10(6): 1754-1763 [DOI: 10.12998/wjcc.v10.i6.1754] [Reference Citation Analysis]
23 Thambi M, Nathan J, Radhakrishnan K. Can change in gut microbiota composition be used as a surrogate marker of treatment efficacy of ketogenic diet in patients with drug-resistant epilepsy? Epilepsy Behav 2020;113:107444. [PMID: 33091747 DOI: 10.1016/j.yebeh.2020.107444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Amlerova J, Šroubek J, Angelucci F, Hort J. Evidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy. Int J Mol Sci 2021;22:5576. [PMID: 34070389 DOI: 10.3390/ijms22115576] [Reference Citation Analysis]
25 Xie X, Wu Y, Xie H, Wang H, Zhang X, Yu J, Zhu S, Zhao J, Sui L, Li S. Polysaccharides, Next Potential Agent for the Treatment of Epilepsy? Front Pharmacol 2022;13:790136. [DOI: 10.3389/fphar.2022.790136] [Reference Citation Analysis]
26 Pracucci E, Pillai V, Lamers D, Parra R, Landi S. Neuroinflammation: A Signature or a Cause of Epilepsy? Int J Mol Sci 2021;22:6981. [PMID: 34209535 DOI: 10.3390/ijms22136981] [Reference Citation Analysis]
27 Citraro R, Lembo F, De Caro C, Tallarico M, Coretti L, Iannone LF, Leo A, Palumbo D, Cuomo M, Buommino E, Nesci V, Marascio N, Iannone M, Quirino A, Russo R, Calignano A, Constanti A, Russo E, De Sarro G. First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat. Epilepsia 2021;62:529-41. [PMID: 33428780 DOI: 10.1111/epi.16813] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
28 Dohm-hansen S, Donoso F, Lucassen PJ, Clarke G, Nolan YM. The gut microbiome and adult hippocampal neurogenesis: A new focal point for epilepsy? Neurobiology of Disease 2022;170:105746. [DOI: 10.1016/j.nbd.2022.105746] [Reference Citation Analysis]
29 Pittman QJ. A gut feeling about the ketogenic diet in epilepsy. Epilepsy Research 2020;166:106409. [DOI: 10.1016/j.eplepsyres.2020.106409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Nesci V, Russo E, Arcidiacono B, Citraro R, Tallarico M, Constanti A, Brunetti A, De Sarro G, Leo A. Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin. Mol Neurobiol 2020;57:4778-89. [PMID: 32785826 DOI: 10.1007/s12035-020-02062-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Darch HT, Collins MK, O'Riordan KJ, Cryan JF. Microbial memories: Sex-dependent impact of the gut microbiome on hippocampal plasticity. Eur J Neurosci 2021;54:5235-44. [PMID: 33458858 DOI: 10.1111/ejn.15119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
32 Wan L, Yang G, Zhang S, Sun Y, Li Z, Wang J, Shi X, Zou L. Investigation of the association between imbalance of the intestinal flora and infantile spasms: a pilot case-control study. Transl Pediatr 2021;10:819-33. [PMID: 34012831 DOI: 10.21037/tp-20-384] [Reference Citation Analysis]